对于患有输血依赖β-thalassemia的儿童的铁化疗法:多年轻是太年轻吗?
Gian Luca Forni1, Antonis Kattamis2, Kevin H M Kuo3
1ForAnemia Foundation, Genoa, Italy.
Pediatric blood & cancer
|May 16, 2024
概括
本综述研究了患有输血依赖β-血症 (TDT) 的幼儿的铁过载,重点关注铁化疗法的最佳时间. 它评估了关于Deferoxamine,Deferiprone和Deferasirox在TDT患者早期干预方面的现有数据.
科学领域:
- 儿科血液学 儿科血液学
- 药理学 药理学是指药理学的学科.
- 临床治疗学 临床治疗学
背景情况:
- 输血依赖β-血症 (TDT) 需要频繁的输血,导致铁过载.
- 如果不管理,TDT患者的铁过载会导致严重的器官损伤.
- 早期检测和管理铁过载对于儿科TDT的长期健康结果至关重要.
研究的目的:
- 审查当前关于TDT幼儿铁过载的证据.
- 探索在这个人群中启动铁化疗法的最佳时间.
- 评估在年轻的TDT患者中可用的铁合剂的疗效和安全性.
主要方法:
- 临床试验和观察性研究的系统审查.
- 对德费洛克萨,德费里和德费拉西洛克斯的数据进行分析.
- 专注于幼儿的子集,特别是6岁以下的子集.
主要成果:
- 铁化疗的证据对于年龄≥2岁且已确定的输血铁过载的儿童是强有力的.
- 新出现的数据表明,在较年轻的儿童中早期启动铁化有潜在的益处和风险,铁过载最小.
- 对于6岁以下的儿童TDT的具体数据仍在开发中.
结论:
- 铁化治疗对于在TDT中管理输血铁过载至关重要.
- 需要进一步的研究,以建立最佳的早期启动协议,以对非常年轻的TDT患者进行铁化.
- 需要考虑年龄和铁负担的个性化治疗策略.
更多相关视频
05:36Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
470
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.3K
相关概念视频
01:22Bone Marrow Sampling and Transplants
325
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
325
02:45Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
01:19Rh Blood Group
1.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K